2019 Symposium

2018 Symposium

2017 Symposium

2016 Symposium

2015 Symposium

2014 Symposium

2013 Symposium

2013 Symposium Photos

2012 Featured Talks

2012 Symposium Photos

2011 Featured Talks

2011 Symposium Photos

Past Symposia in the Press

2013 Featured Talks » Carfilzomib: Investigation in Small Cell Lung Cancer (SCLC)

Carfilzomib: Investigation in Small Cell Lung Cancer (SCLC)

Paula O'Connor, MD, Onyx Pharmaceuticals

» Download Audio

Paula O'Connor, MD, is a board eligible hematologist oncologist with 10 years of industry experience. She currently serves as Senior Medical Director at Onyx Pharmaceuticals, working on Nexavar, Carfilzomib and other pipeline agents. As a clinical science lead, her responsibilities have included protocol development and medical management for registration trials, interpretation of Phase II and III trial data, and interacting with the FDA. Her most recent responsibility is the development of a clinical program for Carfilzomib in Small Cell Lung Cancer.

Prior to joining Onyx, Connor worked for 8 years at Genentech, Inc. Outside of work, she is the mother of an active 4 year old and an avid tennis player.